Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADP-ribosylation factor-like 2 binding protein (ARL2BP), also known as BART, is a highly conserved ciliary protein that acts as an effector for the small GTPase ARL2[1][2]. ARL2BP binds specifically to the GTP-bound form of ARL2, but not to ARL2.GDP or other related GTPases[1][2]. It localizes to the basal body and cilium-associated centriole, particularly in photoreceptors and sperm, where it is critical for the assembly and elongation of microtubule doublets in the axoneme[1][2]. This structural role is essential for normal cilia and flagella morphology and function. Loss or mutation of ARL2BP leads to abnormal cilia formation, shortened axonemes, and cellular dysfunction causing severe retinal degeneration (e.g., retinitis pigmentosa), rod-cone dystrophy, male infertility due to sperm flagellar defects, and additional syndromic ciliopathies such as situs inversus and hydrocephalus[1][2][3]. While ARL2BP interacts with ARL2 and may help guide its localization in ciliated tissues, its main function appears to be independent, acting in cytoskeletal structure and stability of microtubules of the ciliary axoneme. There are currently no drugs or direct therapeutic strategies targeting ARL2BP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor-like 2 binding protein (ARL2BP).